Discontinuing prophylaxis for opportunistic infection: guiding principles.

about

An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons.

P2860

Q45743035-A4C81AB8-C7CE-419C-920A-C737A132934D

P2860

Discontinuing prophylaxis for opportunistic infection: guiding principles.

Item

http://www.wikidata.org/entity/Q41730934

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Discontinuing prophylaxis for opportunistic infection: guiding principles.

@en

type

Item

label

Discontinuing prophylaxis for opportunistic infection: guiding principles.

@en

prefLabel

Discontinuing prophylaxis for opportunistic infection: guiding principles.

@en

P1476

Discontinuing prophylaxis for opportunistic infection: guiding principles.

@en

P2093

Currier JS

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

P304

S66-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/313846

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

30 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12545557

http://www.w3.org/2001/XMLSchema#string

P698

10770914

http://www.w3.org/2001/XMLSchema#string

Discontinuing prophylaxis for opportunistic infection: guiding principles.

about

P2860

P2860

Discontinuing prophylaxis for opportunistic infection: guiding principles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698